Envista (NVST)
(Delayed Data from NYSE)
$16.50 USD
+1.20 (7.84%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $16.52 +0.02 (0.12%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVST 16.50 +1.20(7.84%)
Will NVST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVST
Envista (NVST) Q2 Earnings & Revenues Miss, Margins Fall
Here's What Key Metrics Tell Us About Envista (NVST) Q2 Earnings
NVST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Envista (NVST) Q2 Earnings and Revenues Lag Estimates
Wall Street's Insights Into Key Metrics Ahead of Envista (NVST) Q2 Earnings
Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Other News for NVST
Maintaining Hold on Envista Holdings Amid Financial Challenges and Uncertain Recovery
Envista Holdings: Sell Rating Justified by Poor Q2 Performance and Negative FY24 Guidance
Envista Holdings (NVST) Receives a Buy from Stifel Nicolaus
What's Driving ICU Medical Inc's Surprising 20% Stock Rally?
Morgan Stanley Keeps Their Hold Rating on Envista Holdings (NVST)